Shift verification effort from a single, time-consuming flat run to a more efficient, distributed, and scalable process.

The risky and unpredictable nature of the clinical trial process is a major driver of high costs for pharmaceutical drugs. To justify the costs of drug development, most pharmaceutical companies aim ...

The life sciences industry has recently been rocked by dramatic changes in how healthcare is provided, how drugs are developed and researched, the technologies available that enable companies to ...

The “2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes” incorporates new evidence since the “2013 ACCF/AHA ...

Dual antiplatelet therapy is recommended for patients with acute coronary syndromes (ACS). Ticagrelor or prasugrel is recommended in preference to clopidogrel in patients with ACS who are undergoing ...